Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial [Phase 3]
A Phase 3 clinical trial evaluating integrated multidisciplinary care for Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2010-10-19Clinical Trial Update: Biofeedback-based Motor Learning to Ameliorate Freezing of Gait [NA]
This clinical trial update describes a biofeedback-based motor learning approach aimed at reducing freezing of gait in Parkinson disease.
-
CLINICAL_TRIALS research · 2010-10-18Clinical Trial Update: A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
A completed survey study investigating whether patients with Parkinson's disease have a higher incidence of melanoma.
-
CLINICAL_TRIALS research · 2010-10-13Clinical Trial Update: Pilot Study of Maintenance Therapy With Intravenous AMANTADINE [NA]
Pilot study update on maintenance therapy with intravenous amantadine for Parkinson's disease; the status is unknown and no phase informatio…
-
FDA approval · 2010-10-11FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Sandoz Inc.'s fixed-dose combination of carbidopa, levodopa, and entacapone under NDA 021485…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-10-11FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ENTACAPONE from Sun Pharmaceutical Industries, expanding its labeling. The change pertains t…
-
FDA approval · 2010-10-08FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for pramipexole dihydrochloride tablets, a dopamine agonist for Parkinso…
-
FDA approval · 2010-10-08FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an original application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited, a generic version of the anti-Par…
-
FDA approval · 2010-10-08FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original application for pramipexole dihydrochloride tablets (generic) for indications corresponding to the refe…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients [Phase 1]
Phase 1 assessment of biodistribution and safety of the radiotracer 123-I MZINT in healthy subjects and Parkinson's disease patients; the tr…
-
FDA approval · 2010-10-06FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for a generic Carbidopa and Levodopa product from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611 [Phase 1]
A Phase 1 study evaluating the safety, tolerability and pharmacokinetic profile of levodopa delivered with continuous administration of ND06…
-
FDA approval · 2010-10-04FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's supplemental application for CARBIDOPA AND LEVODOPA, a generic combination therapy for Parkinson's disease…
-
FDA approval · 2010-10-04FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for Trihexyphenidyl hydrochloride from PAI Holdings (PAI Pharma), establishing its generic produ…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease [Phase 2]
This update notes the completion of a Phase 2 study evaluating the effects of dopaminergic medications on dopamine transporter imaging in Pa…
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life
A completed clinical trial evaluating kinetic tremor in Parkinson disease during pramipexole treatment and its impact on quality of life. Re…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations. [Phase 3]
An open-label safety extension of SLV308 in Parkinson's disease patients with motor fluctuations, completed after the Phase 3 S308.3.002 stu…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease [Phase 3]
This Phase 3 trial compares safinamide at 50 mg/day and 100 mg/day with placebo in mid-to-late stage Parkinson's disease, assessing efficacy…
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease [Phase 4]
A Phase 4 study evaluated the tolerability of duloxetine in patients with major depressive disorder and Parkinson's disease; results were po…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Levodopa Concentration Profile With Stalevo 75/125 mg [Phase 1]
Phase 1 study evaluating the concentration profile of Stalevo 75/125 mg (levodopa/carbidopa/entacapone) in Parkinson's disease; the trial ha…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Glutathione (GSH) In The Treatment of Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating glutathione (GSH) for the treatment of Parkinson's disease has completed, sponsored by the University of…
-
CLINICAL_TRIALS trial_result · 2010-07-21Clinical Trial Update: A Trial of MitoQ for the Treatment of People With Parkinson's Disease [Phase 2]
Phase 2 trial of MitoQ for Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2010-07-21Clinical Trial Update: Parkinson's Disease Registry of the Muhammad Ali Parkinson Center
Describes a Parkinson's disease registry sponsored by the Muhammad Ali Parkinson Research Center. The current status of the registry is unkn…
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients [NA]
A completed trial reports evidence that deep brain stimulation may have antidepressant effects in patients with Parkinson's disease, includi…
-
CLINICAL_TRIALS research · 2010-05-28Clinical Trial Update: Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease [Phase 2, Phase 3]
A clinical trial is investigating the effectiveness of a Traditional Chinese Medicinal Mixture for Parkinson disease in Phase 2/Phase 3, wit…